Suppr超能文献

在帕金森病果蝇模型中,Tau与α-突触核蛋白之间的相互作用增强了神经毒性。

Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.

作者信息

Roy Bidisha, Jackson George R

机构信息

Mitchell Center for Neurodegenerative Diseases.

出版信息

Hum Mol Genet. 2014 Jun 1;23(11):3008-23. doi: 10.1093/hmg/ddu011. Epub 2014 Jan 14.

Abstract

Clinical and pathological studies have suggested considerable overlap between tauopathies and synucleinopathies. Several genome-wide association studies have identified alpha-Synuclein (SNCA) and Tau (MAPT) polymorphisms as common risk factors for sporadic Parkinson's disease (PD). However, the mechanisms by which subtle variations in the expression of wild-type SNCA and MAPT influence risk for PD and the underlying cellular events that effect neurotoxicity remain unclear. To examine causes of neurotoxicity associated with the α-Syn/Tau interaction, we used the fruit fly as a model. We utilized misexpression paradigms in three different tissues to probe the α-Syn/Tau interaction: the retina, dopaminergic neurons and the larval neuromuscular junction. Misexpression of Tau and α-Syn enhanced a rough eye phenotype and loss of dopaminergic neurons in fly tauopathy and synucleinopathy models, respectively. Our findings suggest that interactions between α-Syn and Tau at the cellular level cause disruption of cytoskeletal organization, axonal transport defects and aberrant synaptic organization that contribute to neuronal dysfunction and death associated with sporadic PD. α-Syn did not alter levels of Tau phosphorylated at the AT8 epitope. However, α-Syn and Tau colocalized in ubiquitin-positive aggregates in eye imaginal discs. The presence of Tau also led to an increase in urea soluble α-Syn. Our findings have important implications in understanding the cellular and molecular mechanisms underlying α-Syn/Tau-mediated synaptic dysfunction, which likely arise in the early asymptomatic phase of sporadic PD.

摘要

临床和病理研究表明,tau蛋白病和α-突触核蛋白病之间存在相当大的重叠。几项全基因组关联研究已确定α-突触核蛋白(SNCA)和tau蛋白(MAPT)多态性是散发性帕金森病(PD)的常见风险因素。然而,野生型SNCA和MAPT表达的细微变化影响PD风险的机制以及导致神经毒性的潜在细胞事件仍不清楚。为了研究与α-突触核蛋白/ tau蛋白相互作用相关的神经毒性原因,我们以果蝇为模型。我们在三种不同组织中利用错误表达模式来探究α-突触核蛋白/ tau蛋白的相互作用:视网膜、多巴胺能神经元和幼虫神经肌肉接头。在果蝇tau蛋白病和α-突触核蛋白病模型中,tau蛋白和α-突触核蛋白的错误表达分别增强了粗糙眼表型和多巴胺能神经元的丧失。我们的研究结果表明,α-突触核蛋白和tau蛋白在细胞水平上的相互作用会导致细胞骨架组织破坏、轴突运输缺陷和异常的突触组织,从而导致与散发性PD相关的神经元功能障碍和死亡。α-突触核蛋白不会改变在AT8表位磷酸化的tau蛋白水平。然而,α-突触核蛋白和tau蛋白在眼成虫盘中的泛素阳性聚集体中共定位。tau蛋白的存在也导致尿素可溶性α-突触核蛋白增加。我们的研究结果对于理解α-突触核蛋白/ tau蛋白介导的突触功能障碍的细胞和分子机制具有重要意义,这种功能障碍可能发生在散发性PD的早期无症状阶段。

相似文献

1
Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.
Hum Mol Genet. 2014 Jun 1;23(11):3008-23. doi: 10.1093/hmg/ddu011. Epub 2014 Jan 14.
2
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.
5
Distinct CSF α-synuclein aggregation profiles associated with Alzheimer's disease phenotypes and MCI-to-AD conversion.
J Prev Alzheimers Dis. 2025 Feb;12(2):100040. doi: 10.1016/j.tjpad.2024.100040. Epub 2025 Jan 3.
6
Pathological α-synuclein elicits granulovacuolar degeneration independent of tau.
Transl Neurodegener. 2025 Jun 19;14(1):31. doi: 10.1186/s40035-025-00494-5.
7
Gene delivery of SUMO1-derived peptide rescues neuronal degeneration and motor deficits in a mouse model of Parkinson's disease.
Mol Ther. 2025 Jul 2;33(7):3056-3072. doi: 10.1016/j.ymthe.2025.04.005. Epub 2025 Apr 5.
8
Distinct subcellular localization of tau and alpha-synuclein in lewy body disease.
Acta Neuropathol Commun. 2025 Jan 21;13(1):14. doi: 10.1186/s40478-024-01913-w.
10
LRP1 at the crossroads of Parkinson's and Alzheimer's: Divergent roles in α-synuclein and amyloid pathology.
Eur J Pharmacol. 2025 Sep 5;1002:177830. doi: 10.1016/j.ejphar.2025.177830. Epub 2025 Jun 6.

引用本文的文献

1
Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein.
Mol Neurodegener. 2025 Aug 12;20(1):90. doi: 10.1186/s13024-025-00879-0.
2
Exploring the versatility of as a model organism in biomedical research: a comprehensive review.
Fly (Austin). 2025 Dec;19(1):2420453. doi: 10.1080/19336934.2024.2420453. Epub 2024 Dec 25.
5
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration.
Transl Neurodegener. 2024 Mar 26;13(1):16. doi: 10.1186/s40035-024-00407-y.
7
Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review.
Front Mol Neurosci. 2023 Apr 24;16:1172197. doi: 10.3389/fnmol.2023.1172197. eCollection 2023.
9
Exploring therapeutic potential of mitophagy modulators using models of Parkinson's disease.
Front Aging Neurosci. 2022 Oct 19;14:986849. doi: 10.3389/fnagi.2022.986849. eCollection 2022.

本文引用的文献

2
Glial-derived prodegenerative signaling in the Drosophila neuromuscular system.
Neuron. 2011 Dec 8;72(5):760-75. doi: 10.1016/j.neuron.2011.09.031.
3
Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation.
Hum Mol Genet. 2011 Dec 15;20(24):4947-77. doi: 10.1093/hmg/ddr432. Epub 2011 Sep 23.
4
Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila.
Hum Mol Genet. 2011 Oct 1;20(19):3738-45. doi: 10.1093/hmg/ddr290. Epub 2011 Jun 24.
5
6
Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.
Eur J Neurosci. 2011 May;33(9):1598-610. doi: 10.1111/j.1460-9568.2011.07660.x. Epub 2011 Apr 1.
7
Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.
PLoS One. 2011 Mar 21;6(3):e17953. doi: 10.1371/journal.pone.0017953.
10
Membrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism.
PLoS One. 2010 Dec 13;5(12):e14292. doi: 10.1371/journal.pone.0014292.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验